The Rosen Law Firm, a global investor rights law firm, is informing investors who bought Altimmune, Inc. (NASDAQ: ALT) stock during a specified period of a significant deadline. The firm is representing investors in a class action lawsuit against Altimmune.
The class period for the lawsuit runs from August 10, 2023, to June 25, 2025. Investors who purchased Altimmune securities during this time may be eligible for compensation. The firm emphasizes that participation does not require any upfront costs due to the contingency fee arrangement.
The deadline for potential lead plaintiffs to contact the court is October 6, 2025. A lead plaintiff acts on behalf of other class members in managing the legal proceedings. Rosen Law Firm encourages investors to choose counsel carefully, highlighting its own extensive experience and successes in securities class action litigation.
The lawsuit alleges that Altimmune provided false and misleading information about the results of its IMPACT Phase 2b MASH trial. Specifically, the complaint states that the company overstated the trial’s success, failing to disclose crucial information about the placebo group’s responses. This omission, the lawsuit argues, led to a misrepresentation of the trial’s results and ultimately caused investor losses.
Rosen Law Firm boasts a strong track record, including securing the largest-ever securities class action settlement against a Chinese company at the time and consistent top rankings for the number of securities class action settlements. They highlight their extensive experience and resources, contrasting their capabilities with firms that may primarily act as intermediaries.
The firm emphasizes that the selection of a lead plaintiff does not guarantee a specific outcome, nor does it prevent investors from remaining absent class members. Investors have the option to retain their own counsel, or remain inactive and simply be included in any potential settlement.
Anyone interested in learning more about the lawsuit and their potential involvement should contact Phillip Kim, Esq. at the Rosen Law Firm. The firm’s contact information, including phone number and email address, is publicly available. The firm notes that no class has yet been certified, and representation is contingent upon actively engaging with the firm.
Related
